Emcure Pharmaceuticals saw a significant block deal where BC Investments IV Limited sold 18 lakh shares for Rs 289 crore to Norges Bank. The pharma company, which manufactures APIs and formulations, has shown strong performance with a 67% return in the past 12 months and a 50% YoY growth in net profit.
